Skip to content

Safety evaluation of an excessive consumption of kiwifruit extract

Safety evaluation of an excessive consumption of kiwifruit extract - Safety evaluation of an excessive consumption of kiwifruit extract

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000032657
Enrollment
24
Registered
2018-07-01
Start date
2018-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nothing (healthy subject)

Interventions

Kiwifruit extract 1,800 mg, 12weeks Placebo, 12weeks

Sponsors

Omnica Co.,Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Healthy Japanese males and females 2. BMI>=18.5 and <25 kg/m2

Exclusion criteria

Exclusion criteria: 1. Subjects who have at least one previous medical history of malignant tumor, heart failure or myocardial infarction 2. Subjects who are patient or have history of cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension or other chronic diseases 3. Subjects who have undergone gastrointestinal tract surgery; except appendectomy 4. Subjects who are currently taking medicines (include herbal medicines) and/or supplements 5. Subjects who are allergic to medicines or the test material of this trial 6. Subjects who are or are possibly pregnant, or are lactating 7. Subjects who participate in other clinical trials in the past 3 months 8. Subjects who work time is irregular 9. Subjects who have a smoking habit 10. Subjects who have been determined ineligible by principal investigator for other reasons

Design outcomes

Primary

MeasureTime frame
Blood biochemical test(0w, 6w, 12w)

Secondary

MeasureTime frame
Body measurement (0w, 6w, 12w) Hematologic test(0w, 6w, 12w) Urine analysis(0w, 6w, 12w) Doctor's questions(0w, 6w, 12w) Adverse events Questionnaires

Countries

Japan

Contacts

Public ContactJunko Hirota

Omnica Co.,Ltd Research and development Dept.

hirota@omnica.co.jp03-5840-9815

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026